Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Venlafaxine Stories

3471cecb79734a5f5ae940ca31dde76c1
2007-04-17 17:20:00

CHICAGO -- Authors of a new comprehensive analysis of antidepressants for children and teenagers say the benefits of treatment trump the small risk of increasing some patients' chances of having suicidal thoughts and behaviors. The risk they found is lower than the one the Food and Drug Administration identified in 2004, the year the agency warned the public about the drugs' risks in children. After the warning, U.S. youth suicides increased and some mental health experts said reluctance to...

2006-07-19 14:50:00

WASHINGTON (Reuters) - Information about risks to newborns and migraine sufferers linked to some of the world's most widely used antidepressants should be added to the drug labels, the U.S. Food and Drug Administration said on Wednesday. The FDA warned that taking antidepressants known as SSRIs -- including Prozac and Zoloft -- or certain SNRIs in combination with migraine drugs known as triptans could result in a life-threatening condition called serotonin syndrome. It also warned consumers...

2006-07-19 13:24:11

WASHINGTON (Reuters) - The use of some migraine drugs with certain antidepressants can cause a fatal condition in which patients experience hallucinations, overactive reflexes and rapid heart beat, the U.S. Food and Drug Administration warned on Wednesday. The antidepressants of concern include selective serotonin reuptake inhibitors and selective serotonin/norepinephrine reuptake inhibitors, the FDA said. Patients should talk to their doctors before discontinuing antidepressant or...

2006-05-23 13:37:53

By Ransdell Pierson NEW YORK (Reuters) - Shares of Wyeth fell on Tuesday following the disclosure that an experimental anti-depressant, which was designed to be improvement over its top-selling Effexor XR drug, caused nausea in many patients in a clinical trial. Wyeth shares were down $1.25, or 2.6 percent, to $47.58 in afternoon trading on the New York Stock Exchange. Data from a late-stage trial of the anti-depressant, called DVS-233, were presented on Monday at a scientific...

2006-05-23 13:35:00

By Ransdell Pierson NEW YORK (Reuters) - Shares of Wyeth fell on Tuesday following the disclosure that an experimental anti-depressant, which was designed to be improvement over its top-selling Effexor XR drug, caused nausea in many patients in a clinical trial. Wyeth shares were down $1.25, or 2.6 percent, to $47.58 in afternoon trading on the New York Stock Exchange. Data from a late-stage trial of the anti-depressant, called DVS-233, were presented on Monday at a scientific meeting of the...

2006-03-23 00:35:00

By Karla Gale NEW YORK -- A new study shows that when patients with major depression fail to respond to a course of Celexa (citalopram) or cannot tolerate its side effects, approximately one third of those whose treatment is augmented with either bupropion (Wellbutrin) or Buspar (buspirone) will experience a remission of their depression. If they are instead switched to Wellbutrin, Zoloft (sertraline), or Effexor (venlafaxine), about one out of four will remit. These findings, based on two...

2006-03-07 18:10:00

By Clementine Wallace NEW YORK (Reuters Health) - A single injection of the hormone medroxyprogesterone acetate (MPA) is more effective in reducing menopausal hot flashes than is treatment with the antidepressant pill venlafaxine (Effexor), researchers report. Hormones like MPA and recently marketed antidepressants have been shown to reduce hot flashes, but until now, no comparisons between the two treatments had been made. In a new report in the Journal of Clinical Oncology, a team led by...

2006-03-07 11:49:16

NEW YORK (Reuters Health) - During the early phase of antidepressant treatment of pediatric patients, there is a slight increased risk of suicidal thoughts and behavior, the results of several studies suggest. However, the US Food and Drug Administration research team that conducted the study review does not discourage the use of antidepressant drugs for children. Instead, they advise "close monitoring of patients as a way of managing the risk of suicidality," according to their...

2006-03-06 11:22:54

By Karla Gale NEW YORK (Reuters Health) - Patients with coronary artery disease may be at increased risk of death while using antidepressant drugs, according to the results of an observational study reported at the American Psychosomatic Society in Denver. However, "people with heart disease should definitely not stop taking their antidepressants, because we do not know if antidepressants were causing this (increased risk) or if it was due to some other characteristics of folks who...

2005-09-28 10:54:28

LONDON (Agence de Presse Medicale) - Antidepressants should not be used as first-line treatment in patients younger than 18 years old -- even for moderate-to-severe or psychotic depression -- Britain's health economics watchdog, the National Institute for Clinical Excellence, said on Wednesday. In children (5-11 years old) and young people (12-18) with depression, psychological therapy such as group cognitive behavior therapy should be the first-line treatment, backed up by advice on...